BDB562697

Smad2 (pS465/pS467)/Smad3 (pS423/pS425) Mouse, PE-CF594, Clone: O72-670, BD

Manufacturer: BD Biosciences

Select a Size

Pack Size SKU Availability Price
Each of 1 BDB562697-Each-of-1 In Stock ₹ 28,257.50

BDB562697 - Each of 1

₹ 28,257.50

In Stock

Quantity

1

Base Price: ₹ 28,257.50

GST (18%): ₹ 5,086.35

Total Price: ₹ 33,343.85

Antigen

Smad2 (pS465/pS467)/Smad3 (pS423/pS425)

Classification

Monoclonal

Conjugate

PE-CF594

Formulation

Aqueous buffered solution containing BSA and ≤0.09% sodium azide.

Immunogen

Phosphorylated Human Smad2 Peptide

Quantity

50 Tests

Primary or Secondary

Primary

Content And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.

Applications

Flow Cytometry

Clone

O72-670

Description

SMAD2, SMAD3; MADH2, MADH3; MAD homolog 2, MAD homolog 3

Host Species

Mouse

Purification Method

Affinity Purified

Regulatory Status

RUO

Target Species

Human, Mouse

Isotype

IgG1 κ

Related Products

Img

BD Biosciences

BDB562586

--

Img

BD Biosciences

BDB562696

--

Img

BD Biosciences

BDB562509

--

Img

BD Biosciences

BDB562069

--

Img

BD Biosciences

BDB562673

--

Img

BD Biosciences

BDB562480

--

Img

BD Biosciences

BDB562465

--

Img

BD Biosciences

BDB562458

--

Description

  • The O72-670 monoclonal antibody specifically binds to the Smad2 protein phosphorylated at the Ser465/467 sites and the Smad3 protein phosphorylated at the Ser423/425 sites
  • Smad2 and Smad3 are members of the Smad superfamily with observed molecular weights of 60 kDa and 52 kDa, respectively
  • The Smad family consists of three subfamilies: receptor regulated Smads or R-Smads, including Smads1, 2, 3, 5, and 8; common partner Smad, or Co-Smad, including Smad4; and inhibitory Smads, or I-Smad, including Smads 6 and 7
  • Activation of TGF-beta superfamily serine/threonine kinase receptors, such as TGF-beta, activin and BMP receptors, by their bound ligands leads to the phosphorylation of R-Smads at several sites
  • It has been shown that the ligand-bound TGF-beta type I receptor directly phosphorylates Ser465 and Ser467 of Smad2 and Ser423 and Ser425 of Smad3
  • Phosphorylated R-Smads form complexes with Co-Smad and translocate into the nucleus to regulate transcription affecting a wide range of critical cellular processes including cell-fate determination, proliferation, morphogenesis, differentiation and apoptosis
  • The inhibitory Smads inhibit this pathway through two potential mechanisms: either by preventing R-Smads from binding to their corresponding receptors and/or by competing with Smad4, the Co-Smad, from binding to R-Smads
  • High level expression of phosphorylated Smad2 has been associated with poor prognosis in late stage gastric carcinoma
  • Roles for Smad2 have been described in thymopoiesis and the TGF-β-mediated induction of regulatory T cells and Th17 cells
  • The specificity of theO72-670 mAb was confirmed by Western blot and immunohistochemistry using unconjugated antibody
  • This antibody is conjugated to BD Horizon™ PE-CF594, which has been developed exclusively by BD Biosciences as a better alternative to PE-Texas Red™
  • PE-CF594 excites and emits at similar wavelengths to PE-Texas Red™ yet exhibits improved brightness and spectral characteristics
  • Due to PE having maximal absorption peaks at 496nm and 564nm, PE-CF594 can be excited by the blue (488-nm), green (532-nm) and yellow-green (561-nm) lasers and can be detected with the same filter set as PE-Texas Red™ (eg 610/20-nm filter).